Advertisement
Schizophrenia Research Series: Phenomenology and Pathophysiology| Volume 46, ISSUE 7, P882-891, October 01, 1999

22q11 deletion syndrome: a genetic subtype of schizophrenia

  • Anne S Bassett
    Correspondence
    Address reprint requests to Dr. Anne Bassett, Schizophrenia Research Program, Centre for Addiction & Mental Health, Queen Street Division, 1001 Queen Street West, Toronto, Ontario M6J 1H4, Canada
    Affiliations
    Schizophrenia Research Program, Centre for Addiction & Mental Health, Queen Street Division, Toronto, Ontario, Canada

    Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    Search for articles by this author
  • Eva W.C Chow
    Affiliations
    Schizophrenia Research Program, Centre for Addiction & Mental Health, Queen Street Division, Toronto, Ontario, Canada

    Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    Search for articles by this author

      Abstract

      Schizophrenia is likely to be caused by several susceptibility genes and may have environmental factors that interact with susceptibility genes and/or nongenetic causes. Recent evidence supports the likelihood that 22q11 Deletion Syndrome (22qDS) represents an identifiable genetic subtype of schizophrenia. 22qDS is an under-recognized genetic syndrome associated with microdeletions on chromosome 22 and a variable expression that often includes mild congenital dysmorphic features, hypernasal speech, and learning difficulties. Initial evidence indicates that a minority of patients with schizophrenia (∼2%) may have 22qDS and that prevalence may be somewhat higher in subpopulations with developmental delay. This paper proposes clinical criteria (including facial features, learning disabilities, hypernasal speech, congenital heart defects and other congenital anomalies) to aid in identifying patients with schizophrenia who may have this subtype and outlines features that may increase the index of suspicion for this syndrome. Although no specific causal gene or genes have yet been identified in the deletion region, 22qDS may represent a more homogeneous subtype of schizophrenia. This subtype may serve as a model for neurodevelopmental origins of schizophrenia that could aid in delineating etiologic and pathogenetic mechanisms.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Amati F.
        • Mari A.
        • Digilio M.C.
        • et al.
        22q11 deletions in isolated and syndromic patients with tetralogy of Fallot.
        Hum Genet. 1995; 95: 479-482
        • Bassett A.S.
        • Hodgkinson K.
        • Chow E.W.C.
        • Correia S.
        • Scutt L.
        • Weksberg R.
        22q11 deletion syndrome in adults with schizophrenia.
        Am J Med Genet. 1998; 81: 328-337
        • Bogerts B.
        Recent advances in the neuropathology of schizophrenia.
        Schizophr Bull. 1993; 19: 431-445
        • Budarf M.L.
        • Collins J.
        • Gong W.
        • et al.
        Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene.
        Nature Genet. 1995; 10: 269-277
        • Cannon M.
        • Murray R.M.
        Neonatal origins of schizophrenia.
        Arch Dis Child. 1998; 78: 1-8
        • Carlson C.
        • Sirotkin H.
        • Pandita R.
        • et al.
        Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.
        Am J Hum Genet. 1997; 61: 620-629
        • Carpenter W.T.
        • Heinrichs D.W.
        • Wagman A.M.I.
        Deficit and nondeficit forms of schizophrenia.
        Am J Psychiatry. 1988; 145: 578-583
      1. Chow EWC, Mikulis D, Scutt L, Zipursky RB, Weksberg R, Bassett AS (in press): Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry.

        • Chow E.
        • Zipursky R.B.
        • Mikulis D.
        • Scutt L.
        • Weksberg R.
        • Bassett A.S.
        MRI findings in adults with 22q11 deletion syndrome (22qDS) and schizophrenia.
        Schizophr Res. 1999; 36: 89
        • Chow E.W.C.
        • Bassett A.S.
        • Weksberg R.
        Velo-cardio-facial syndrome and psychotic disorders.
        Am J Med Genet. 1994; 54: 107-112
        • Cuneo B.F.
        • Driscoll D.A.
        • Gidding S.S.
        • Langman C.B.
        Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome.
        Am J Med Genet. 1997; 69: 50-55
        • Dallapiccola B.
        • Pizzuti A.
        • Novelli G.
        How many breaks do we need to CATCH on 22q11?.
        Am J Hum Genet. 1996; 59: 7-11
        • Daniels J.K.
        • Williams N.M.
        • Williams J.
        • et al.
        No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity.
        Am J Psychiatry. 1996; 153: 268-270
        • Daw S.C.M.
        • Taylor C.
        • Kramau M.
        • et al.
        A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
        Nature Genet. 1996; 13: 458-460
        • Debrus S.
        • Berger G.
        • de Meeus A.
        • et al.
        Familial non-syndromic conotruncal defects are not associated with a 22q11 microdeletion.
        Hum Genet. 1996; 97: 138-144
        • Degreef G.
        • Ashtari M.
        • Bogerts B.
        • et al.
        Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients.
        Arch Gen Psychiatry. 1992; 49: 531-537
        • Demczuk S.
        • Aledo R.
        • Zucman J.
        • et al.
        Cloning of a balanced translocation breakpoint in the DiGeorge syndrome critical region and isolation of a novel potential adhesion receptor gene in its vicinity.
        Hum Mol Genet. 1995; 4: 551-558
        • Demczuk S.
        • Aurias A.
        DiGeorge syndrome and related syndromes associated with 22q11.2 deletions.
        Annales de Genetique. 1995; 38: 59-76
        • Done D.J.
        • Crow T.J.
        • Johnstone E.C.
        • Sacker A.
        Childhood antecedents of schizophrenia and affective illness.
        Brit Med J. 1994; 309: 699-703
        • Driscoll D.A.
        • Salvin J.
        • Sellinger B.
        • et al.
        Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes.
        J Med Genet. 1993; 30: 813-817
        • du Montcel S.T.
        • Mendizabal H.
        • Ayme S.
        • Levy A.
        • Philip N.
        Prevalence of 22q11 microdeletion.
        J Med Genet. 1996; 33: 719
        • Famy C.
        • Streissguth A.P.
        • Unis A.S.
        Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects.
        Am J Psychiatry. 1998; 155: 552-554
        • Finkelstein Y.
        • Zohar Y.
        • Nachmani A.
        • et al.
        The otolaryngologist and the patient with velocardiofacial syndrome.
        Arch Otolaryngol Head Neck Surg. 1993; 119: 563-569
        • Fryer A.
        Monozygotic twins with 22q11 deletion and discordant phenotypes.
        J Med Genet. 1996; 33: 261-264
        • Goldberg R.
        • Motzkin B.
        • Marion R.
        • Scambler P.J.
        • Shprintzen R.J.
        Velo-cardio-facial syndrome.
        Am J Med Genet. 1993; 45: 313-319
        • Golding-Kushner K.J.
        • Weller G.
        • Shprintzen R.J.
        Velo-cardio-facial syndrome.
        J Craniofacial Gen Dev Biol. 1985; 5: 259-266
        • Gothelf D.
        • Frisch A.
        • Munitz H.
        • et al.
        Velocardiofacial manifestations and microdeletions in schizophrenic patients.
        Am J Med Genet. 1997; 72: 455-461
        • Gottesman I.I.
        • Shields J.
        Schizophrenia. Cambridge University Press, Cambridge1982
        • Green M.F.
        What are the functional consequences of neurocognitive deficits in schizophrenia?.
        Am J Psychiatry. 1996; 153: 321-329
        • Green M.F.
        • Satz P.
        • Galer D.J.
        • Ganzell S.
        • Kharabi F.
        Minor physical anomalies in schizophrenia.
        Schizophr Bull. 1989; 15: 91-99
        • Greenberg F.
        DiGeorge syndrome.
        J Med Genet. 1993; 30: 803-806
        • Griffiths T.D.
        • Sigmundsson T.
        • Takei N.
        • et al.
        Minor physical anomalies in familial and sporadic schizophrenia.
        J Neurosurg Psychiatry. 1998; 64: 56-60
        • Guy J.D.
        • Majorski L.V.
        • Wallace C.J.
        • et al.
        The incidence of minor physical anomalies in adult male schizophrenics.
        Schizophr Bull. 1983; 9: 571-582
        • Haapanen M.L.
        • Somer M.
        Velocardiofacial syndrome.
        Folia Phoniatrica. 1993; 45: 239-246
        • Häfner H.
        • an der Heiden W.
        Epidemiology of schizophrenia.
        Can J Psychiatry. 1997; 42: 139-151
        • Halford S.
        • Lindsay E.
        • Nayudu M.
        • Carey A.H.
        • Baldini A.
        • Scambler P.J.
        Lowcopy-number repeat sequences flank the DiGeorge/velo-cardio-facial syndrome loci at 22q11.
        Hum Mol Genet. 1993; 2: 191-196
        • Hall J.G.
        CATCH 22.
        J Med Genet. 1993; 30: 801-802
        • Hatchwell E.
        Monozygotic twins with chromosome 22q11 deletion and discordant phenotype.
        J Med Genet. 1996; 33: 261-264
        • Johnstone E.C.
        • Crow T.J.
        • Frith D.C.
        • Husband J.
        • Kreel L.
        Cerebral ventricular size and cognitive impairment in schizophrenia.
        Lancet. 1976; 2: 924-926
        • Jones K.L.
        Smith’s Recognizable Patterns of Human Malformation. 5th ed. WB Saunders, Philadelphia1997
        • Jones P.
        • Rodgers P.B.
        • Murray R.M.
        • Marmot M.
        Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort.
        Lancet. 1994; 344: 1398-1402
        • Karayiorgou M.
        • Morris M.A.
        • Morrow B.
        • et al.
        Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.
        Proc Nat Acad Sci U S A. 1995; 92: 7612-7616
        • Kelly D.
        • Goldberg R.
        • Wilson D.
        • et al.
        Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
        Am J Med Genet. 1993; 45: 308-312
        • Kendler K.S.
        • Diehl S.R.
        The genetics of schizophrenia.
        Schizophr Bull. 1993; 19: 261-284
        • Kok L.L.
        • Solman R.T.
        Velocardiofacial syndrome.
        J Med Genet. 1995; 32: 612-618
      2. Kraepelin E (1971): Dementia Praecox and Paraphrenia, Fascimile 1919 edition. Huntington, New York: Robert E. Krieger Publishing Co. Inc.

        • Kucherlapati R.S.
        • Shprintzen R.J.
        • Baldini A.
        Velo-cardio-facial syndrome.
        Am J Med Genet. 1995; 57: 514-522
        • Kurahashi H.
        • Nakayama T.
        • Osugi Y.
        • et al.
        Deletion mapping of 22q11 in CATCH22 syndrome.
        Am J Hum Genet. 1996; 58: 1377-1381
        • Lachman H.M.
        • Morrow B.
        • Shprintzen R.
        • et al.
        Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.
        Am J Med Genet. 1996; 67: 468-472
      3. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J (1998): Association between catechol-O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 155:835–837.

        • Leana-Cox J.
        • Pangkanon S.
        • Eanet K.R.
        • Curtin M.S.
        • Wulfsberg E.A.
        Familial DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2.
        Am J Med Genet. 1996; 65: 309-316
        • Lévy A.
        • Michel G.
        • Lemerrer M.
        • Philip N.
        Idiopathic thrombocytopenic purpura in two mothers of children with DiGeorge sequence.
        Am J Med Genet. 1997; 69: 356-359
        • Lewis S.
        • Mezey G.
        Clinical correlates of septum pellucidum cavities—an unusual association with psychosis.
        Psychol Med. 1985; 15: 43-54
        • Lieberman J.A.
        Signs and symptoms.
        Arch Gen Psychiatry. 1995; 52: 361-363
        • Lindsay E.A.
        • Goldberg R.
        • Jurecic V.
        • et al.
        Velo-cardio-facial syndrome.
        Am J Med Genet. 1995; 57: 514-522
        • Lindsay E.A.
        • Greenberg F.
        • Shaffer L.G.
        • Shapira S.K.
        • Scambler P.J.
        • Baldini A.
        Submicroscopic deletions at 22q11.2.
        Am J Med Genet. 1995; 56: 191-197
        • Lipson A.H.
        • Yuille D.
        • Angel M.
        • Thompson P.G.
        • Vandervoord J.G.
        • Beckeham E.J.
        Velocardiofacial (Shprintzen) syndrome.
        J Med Genet. 1991; 28: 596-604
        • Lynch D.R.
        • McDonald-McGinn D.M.
        • Zackai E.H.
        • et al.
        Cerebellar atrophy in a patient with velocardiofacial syndrome.
        J Med Genet. 1995; 32: 561-563
        • Mansour A.M.
        • Goldberg R.B.
        • Wang F.M.
        • Shprintzen R.J.
        Ocular findings in the velo-cardio-facial syndrome.
        J Pediatr Opthamol Strabismus. 1987; 24: 263-266
        • Marsh L.
        • Lauriello J.
        • Sullivan E.
        • Pfefferbaum A.
        Neuroimaging in psychiatric disorders.
        in: Bigler E.D. Neuroimaging II Clinical Applications. Plenum Press, New York1996: 73-125
        • Masters C.L.
        • Simms G.
        • Weinman N.A.
        • Multhaup G.
        • McDonald B.L.
        • Beyreuther K.
        Amyloid plaque core protein in Alzheimer disease and Down syndrome.
        Proc Nat Acad Sci U S A. 1985; 82: 4245-4249
        • McGuffin P.
        • Owen M.J.
        • Farmer A.E.
        Genetic basis of schizophrenia.
        Lancet. 1995; 346: 678-682
        • McLean S.D.
        • Saal H.M.
        • Spinner N.B.
        • Emanuel B.S.
        • Driscoll D.A.
        Velo-cardio-facial syndrome.
        Am J Dis Child. 1993; 147: 1212-1216
        • Meinecke P.
        • Beemer F.A.
        • Schinzel A.
        • Kushnick T.
        The velo-cardio-facial (Shprintzen) syndrome.
        Eur J Pediatr. 1986; 145: 539-544
        • Mingarelli R.
        • Digilio M.C.
        • Mari A.
        • et al.
        The search for hemizygosity at 22q11 in patients with isolated cleft palate.
        J Craniofacial Genet Dev Biol. 1996; 16: 118-121
        • Mitnick R.J.
        • Bello J.A.
        • Golding-Kushner K.J.
        • Argamaso R.V.
        • Shprintzen R.J.
        The use of magnetic resonance angiography prior to pharyngeal flap surgery in patients with velocardiofacial syndrome.
        Plast Reconstr Surg. 1996; 97: 908-919
        • Mitnick R.J.
        • Bello J.A.
        • Shprintzen R.J.
        Brain anomalies in velo-cardio-facial syndrome.
        Am J Med Genet. 1994; 54: 100-106
        • Moldin S.O.
        • Gottesman I.I.
        Genes, experience, and chance in schizophrenia—positioning for the 21st century.
        Schizophr Bull. 1997; 23: 547-561
        • Monaco G.
        • Pignata C.
        • Rossi E.
        • Mascellaro O.
        • Cocozza S.
        • Ciccimarra F.
        DiGeorge anomaly associated with 10p deletion.
        Am J Med Genet. 1991; 39: 215-216
        • Morrow B.
        • Goldberg R.
        • Carlson C.
        • et al.
        Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome.
        Am J Hum Genet. 1995; 56: 1391-1403
        • Motzkin B.
        • Marion R.
        • Goldberg R.
        • Shprintzen R.
        • Saenger P.
        Variable phenotypes in velocardiofacial syndrome with chromosomal deletion.
        J Pediatr. 1993; 123: 406-410
        • Murphy K.C.
        • Jones R.G.
        • Griffiths E.
        • Thompson P.W.
        • Owen M.J.
        Chromosome 22q11 deletions. An under-recognised cause of idiopathic learning disability.
        Brit J Psychiatry. 1998; 172: 180-183
        • Murphy K.C.
        • Owen M.J.
        The behavioural phenotype in velo-cardio-facial-syndrome.
        Am J Hum Genet. 1997; 61: A5
        • Murray R.
        • Lewis S.W.
        • Revely A.M.
        Towards an aetiological classification of schizophrenia.
        Lancet. 1985; i: 1023-1026
        • Murray R.M.
        • Lewis S.W.
        Is schizophrenia a neurodevelopmental disorder?.
        Brit Med J. 1987; 295: 681-682
        • Nickel R.E.
        • Pillers D.A.M.
        • Merkens M.
        • et al.
        Velo-cardio-facial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region.
        Am J Med Genet. 1994; 52: 445-449
        • O’Callaghan E.
        • Larkin C.
        • Kinsella A.
        • Waddington J.L.
        Familial, obstetric, and other clinical correlates of minor physical anomalies in schizophrenia.
        Am J Psychiatry. 1991; 148: 479-483
        • Papolos D.F.
        • Faedda G.L.
        • Veit S.
        • et al.
        Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome.
        Am J Psychiatry. 1996; 153: 1541-1547
        • Pinto-Escalante D.
        • Ceballos-Quintal J.M.
        • Castillo-Zapata I.
        • Canto-Herrera J.
        Full mosaic monosomy 22 in a child with DiGeorge syndrome facial appearance.
        Am J Med Genet. 1998; 76: 150-153
        • Pizzuti A.
        • Novelli G.
        • Ratti A.
        • et al.
        UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome.
        Hum Mol Genet. 1997; 6: 259-265
        • Propping P.
        • Nothen M.M.
        Schizophrenia.
        Proc Nat Acad Sci U S A. 1995; 92: 7607-7608
        • Pulver A.E.
        • Nestadt G.
        • Goldberg R.
        • et al.
        Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives.
        J Nerv Ment Dis. 1994; 182: 476-478
        • Ravnan J.B.
        • Chen E.
        • Golabi M.
        • Lebo R.V.
        Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
        Am J Med Genet. 1996; 66: 250-256
        • Russell A.J.
        • Munro J.C.
        • Jones P.B.
        • Hemsley D.R.
        • Murray R.M.
        Schizophrenia and the myth of intellectual decline.
        Am J Psychiatry. 1997; 154: 635-639
        • Ryan A.K.
        • Goodship J.A.
        • Wilson D.I.
        • et al.
        Spectrum of clinical features associated with interstitial chromosome 22q11 deletions.
        J Med Genet. 1997; 34: 798-804
        • Scambler P.J.
        • Kelly D.
        • Lindsay E.
        • et al.
        Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus.
        Lancet. 1992; 339: 1138-1139
        • Schizophrenia Collaborative Linkage Group for Chromosome 22
        A transmission disequilibrium and linkage analysis of D22S278 marker alleles in 574 families.
        Schizophr Res. 1998; 32: 115-121
        • Sedlackova E.
        The syndrome of the congenitally shortened velum the dual innervation of the soft palate.
        Folia Phoniatrica. 1967; 19: 441-450
        • Shprintzen R.J.
        • Goldberg R.
        • Golding-Kushner K.J.
        • Marion R.W.
        Late-onset psychosis in the velo-cardio-facial syndrome (letter).
        Am J Med Genet. 1992; 42: 141-142
        • Shprintzen R.J.
        • Goldberg R.B.
        • Lewin M.L.
        • et al.
        A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities.
        Cleft Palate J. 1978; 15: 56-62
        • Shprintzen R.J.
        • Goldberg R.B.
        • Young D.
        • Wolford L.
        The velo-cardio-facial syndrome.
        Pediatrics. 1981; 67: 167-172
        • Sirotkin H.
        • Morrow B.
        • DasGupta R.
        • et al.
        Isolation of a new clathrin heavy chain gene with muscle-specific expression from the region commonly deleted in velo-cardio-facial syndrome.
        Hum Mol Genet. 1996; 5: 617-624
        • Sirotkin H.
        • O’Donnell H.
        • DasGupta R.
        • et al.
        Identification of a new human catenin gene family member (ARVCF) from the region deleted in velo-cardio-facial syndrome.
        Genomics. 1997; 41: 75-83
        • Sutherland H.F.
        • Wadey R.
        • Mckie J.M.
        • et al.
        Identification of a novel transcript disrupted by a balanced translocation associated with DiGeorge syndrome.
        Am J Hum Genet. 1996; 59: 23-31
        • Swillen A.
        • Devriendt K.
        • Legius E.
        • et al.
        Intelligence and psychosocial adjustment in velocardiofacial syndrome.
        J Med Genet. 1997; 34: 453-458
        • Takahashi K.
        • Kido S.
        • Hoshino K.
        • Ogawa K.
        • Ohashi H.
        • Fukushima Y.
        Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations.
        Eur J Pediatr. 1995; 154: 878-881
        • Thomas I.T.
        • Frias J.L.
        The heart in selected congenital malformations a lesson in pathogenetic relationships.
        Ann Clin Lab Sci. 1987; 17: 207-210
        • Turk J.
        • Hill P.
        Behavioural phenotypes in dysmorphic syndromes.
        Clin Dysmorphol. 1995; 4: 105-115
        • Turner T.H.
        Schizophrenia and mental handicap.
        Psychol Med. 1989; 19: 301-314
        • Weinberger D.R.
        Implications of normal brain development for the pathogenesis of schizophrenia.
        Arch Gen Psychiatry. 1987; 44: 660-669
        • Weinberger D.R.
        The biological basis of schizophrenia.
        J Clin Psychiatry. 1997; 58: 22-27
        • Winter R.M.
        What’s in a face?.
        Nature Genet. 1996; 12: 124-129
        • Wisniewski K.E.
        • Wisniewski H.M.
        • Wen G.Y.
        Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome.
        Ann Neurol. 1985; 17: 278-282
        • Yamagishi H.
        • Ishii C.
        • Maeda J.
        • et al.
        Phenotypic discordance in monozygotic twins with 22q11.2 deletion.
        Am J Med Genet. 1998; 78: 319-321
        • Yan W.
        • Jacobsen L.K.
        • Krasnewich D.M.
        • et al.
        Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and “multidimensionally impaired.”.
        Am J Med Genet. 1998; 81: 41-43
        • Zipursky R.B.
        • Lambe E.K.
        • Kapur S.
        • Mikulis D.J.
        Cerebral gray matter volume deficits in first episode psychosis.
        Arch Gen Psychiatry. 1998; 55: 540-546
        • Zipursky R.B.
        • Lim K.O.
        • Sullivan E.V.
        • Brown B.W.
        • Pfefferbaum A.
        Widespread cerebral gray matter volume deficits in schizophrenia.
        Arch Gen Psychiatry. 1992; 49: 195-205